Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sirtuin modulators: where are we now? A review of patents from 2015 to 2019
Nicola Mautone, Clemens Zwergel, Antonello Mai, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 6, pp. 389-407
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The ambiguous role of sirtuins in head and neck squamous cell carcinoma
Devaraj Ezhilarasan, Lakshmi Thangavelu, Subha Manoharan, et al.
Oral Diseases (2021) Vol. 28, Iss. 3, pp. 559-567
Closed Access | Times Cited: 116
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 109
SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process
Chiara Lambona, Clemens Zwergel, Sérgio Valente, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1662-1689
Open Access | Times Cited: 20
Emerging roles of SIRT6 in human diseases and its modulators
Gang Liu, Haiying Chen, Hua Liu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 1089-1137
Open Access | Times Cited: 118
Sirtuin Modulators: Past, Present, and Future Perspectives
Francesco Fiorentino, Nicola Mautone, Martina Menna, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 915-939
Open Access | Times Cited: 39
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 852-852
Open Access | Times Cited: 35
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5
Francesco Fiorentino, Carola Castiello, Antonello Mai, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9580-9606
Open Access | Times Cited: 35
MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer
Jialin Shang, Shaobo Ning, Ying‐Yi Chen, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 1, pp. 120-131
Open Access | Times Cited: 49
Redox Homeostasis in Cardiovascular Disease: The Role of Mitochondrial Sirtuins
Alberto Zullo, Rosa Guida, Rosaria Sciarrillo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 23
Activation and inhibition of sirtuins: From bench to bedside
Francesco Fiorentino, Emanuele Fabbrizi, Antonello Mai, et al.
Medicinal Research Reviews (2024)
Open Access | Times Cited: 5
Selective SIRT2 inhibitors as promising anticancer therapeutics: An update from 2016 to 2020
Eslam Roshdy, Muhamad Mustafa, Abd El-Rahman Shaltout, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113709-113709
Closed Access | Times Cited: 29
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells
Clemens Zwergel, Michele Aventaggiato, Sabrina Garbo, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9622-9641
Open Access | Times Cited: 12
Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders
Chenqin Xu, Ji Li, Zhiqiang Liang, et al.
International Journal of Biological Macromolecules (2023) Vol. 256, pp. 128270-128270
Closed Access | Times Cited: 12
Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective
Naomi Scarano, Chiara Brullo, Francesca Musumeci, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 601-601
Open Access | Times Cited: 4
Molecular dynamics simulation on the role of CL5D in accelerating the product dissociation of SIRT6
H.G. Rao, Ting Yang, Yue Wang, et al.
Physical Chemistry Chemical Physics (2025)
Closed Access
SIRT5: a potential target for discovering bioactive natural products
Yuwei Xie, Ning Cai, Xiaohua Liu, et al.
Journal of Natural Medicines (2025)
Open Access
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Jefferson Antônio Leite, Bruno Ghirotto, Vitor Pedro Targhetta, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1496-1511
Open Access | Times Cited: 26
Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays
Elena Abbotto, Beatrice Casini, Francesco Piacente, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1316-1316
Open Access | Times Cited: 9
The influential responsibility of sirtuins in senescence and associated diseases: A review
Deepak Mishra, Lucy Mohapatra, Alok Shiomurti Tripathi, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 3
Virtual Screening in the Identification of Sirtuins’ Activity Modulators
Elena Abbotto, Naomi Scarano, Francesco Piacente, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5641-5641
Open Access | Times Cited: 15
Mitochondrial Sirtuins in Chronic Degenerative Diseases: New Metabolic Targets in Colorectal Cancer
Antonino Colloca, Anna Balestrieri, Camilla Anastasio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3212-3212
Open Access | Times Cited: 14
Biochemical Functions and Clinical Characterizations of the Sirtuins in Diabetes-Induced Retinal Pathologies
Samanta Taurone, Chiara De Ponte, Dante Rotili, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4048-4048
Open Access | Times Cited: 14
Targeting Mitochondria as a Therapeutic Approach for Parkinson’s Disease
Maryam Abrishamdar, Maryam Sadat Jalali, Yaghoob Farbood
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 4, pp. 1499-1518
Closed Access | Times Cited: 14
Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction
Pamela Senesi, Anna Ferrulli, Livio Luzi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7772-7772
Open Access | Times Cited: 18
Flavonoids as Sirtuin Modulators
Fatma Sezer Şenol, Gökçen Eren, İlkay Erdoğan Orhan
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 9, pp. 790-805
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top